Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findingsFilomena Abate, Vincenzo Moschella, Giovanna Calandra-Buonaura et al.|Parkinsonism & Related Disorders|2024Cited by 2
Opicapone in Parkinson’s disease: a real-world, multicenter, retrospective study to identify patient characteristics for sustained treatment benefitClelia Pellicano, Tommaso Schirinzi, Daniele Belvisi et al.|Journal of Neural Transmission|2025Cited by 2
Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NETArianna Cappiello, Failla Gaetano, Sofia Cuoco et al.|Neurological Sciences|2024Cited by 1